Search Results - "Werlenius, O."

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia by Bernson, E, Hallner, A, Sander, F E, Wilsson, O, Werlenius, O, Rydström, A, Kiffin, R, Brune, M, Foà, R, Aurelius, J, Martner, A, Hellstrand, K, Thorén, F B

“…Interactions between killer-immunoglobulin-like receptors (KIRs) and their HLA class I ligands are instrumental in natural killer (NK) cell regulation and…”
Get full text

S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B by Tobiasson, M., Pandzic, T., Illman, J., Nilsson, L., Weström, S., Sollander, K., Ejerblad, E., Olsnes Kittang, A., Olesen, G., Werlenius, O., Björklund, A., Wiggh, J., lindholm, C., Lorentz, F., Rasmussen, B., Cammenga, J., Weber, D., Grönnås, D., Dimitriou, M., Kytölä, S., Walldin, G., Ljungman, P., Groenbeck, K., Mielke, S., Jacobsen, S. E., Ebeling, F., Cavelier, L., Smidstrup Friis, L., Dybedal, I., Hellström‐Lindberg, E.

Get full text

High Functional CD70 Expression on α‐Type 1‐Polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia by Junevik, K., Werlenius, O., Fogelstrand, L., Karlsson‐Parra, A., Andersson, P.‐O.

“…Antigen‐loaded dendritic cells (DCs) used as anticancer vaccine holds promise for therapy, but needs to be optimized. The most frequently described DC vaccine…”
Get full text

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation by Tobiasson, Magnus, Pandzic, Tatjana, Illman, Johanna, Nilsson, Lars, Weström, Simone, Ejerblad, Elisabeth, Olesen, Gitte, Björklund, Andreas, Olsnes Kittang, Astrid, Werlenius, Olle, Lorentz, Fryderyk, Rasmussen, Bengt, Cammenga, Jörg, Weber, Duruta, Lindholm, Carolin, Wiggh, Joel, Dimitriou, Marios, Moen, Ann Elin, Yip Lundström, Laimei, von Bahr, Lena, Baltzer-Sollander, Karin, Jädersten, Martin, Kytölä, Soili, Walldin, Gunilla, Ljungman, Per, Groenbaek, Kirsten, Mielke, Stephan, Jacobsen, Sten Eirik W, Ebeling, Freja, Cavelier, Lucia, Smidstrup Friis, Lone, Dybedal, Ingunn, Hellström-Lindberg, Eva

“…Clinical relapse is the major threat for patients with myelodysplastic syndrome (MDS) undergoing hematopoietic stem-cell transplantation (HSCT). Early…”
Get full text

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS by Lindholm, C., Tobiasson, M., Pandzic, T., Illman, J., Nilsson, L., Weström, S., Ejerblad, E., Olesen, G., Björklund, A., Kittang, A. Olsnes, Werlenius, O., Wiggh, J., Lorentz, F., Rasmussen, B., Cammenga, J., Weber, D., Moen, A.E., Lundström, L.Y., Bahr, L. Von, Dimitriou, M., Kytölä, S., Walldin, G., Ljungman, P., Groenbaek, K., Mielke, S., Jacobsen, S.E., Ebeling, F., Cavelier, L., Friis, L. Smidstrup, Dybedal, I., Hellstrom-Lindberg, E.

Get full text

High Functional CD 70 Expression on α ‐Type 1‐Polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia by Junevik, K., Werlenius, O., Fogelstrand, L., Karlsson‐Parra, A., Andersson, P.‐O.

“…Antigen‐loaded dendritic cells ( DC s) used as anticancer vaccine holds promise for therapy, but needs to be optimized. The most frequently described DC…”
Get full text

High Functional CD70 Expression on [alpha]-Type 1-Polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia by Junevik, K, Werlenius, O, Fogelstrand, L, Karlsson-Parra, A, Andersson, P-O

“…Antigen-loaded dendritic cells (DCs) used as anticancer vaccine holds promise for therapy, but needs to be optimized. The most frequently described DC vaccine…”
Get full text

COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROWAND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS by Lindholm, C, Tobiasson, M, Pandzic, T, Illman, J, Nilsson, L, Westrom, S, Ejerblad, E, Olesen, G, Bjorklund, A, Kittang, AO, Werlenius, O, Wiggh, J, Lorentz, F, Rasmussen, B, Cammenga, J, Weber, D, Moen, AE, Lundstrom, LY, Von Bahr, L, Dimitriou, M, Kytola, S, Walldin, G, Ljungman, P, Groenbaek, K, Mielke, S, Jacobsen, SE, Ebeling, F, Cavelier, L, Friis, LS, Dybedal, I, Hellstrom-Lindberg, E

Get full text

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population by Wedge, Eileen, Hansen, Jakob Werner, Dybedal, Ingunn, Creignou, Maria, Ejerblad, Elisabeth, Lorenz, Fryderyk, Werlenius, Olle, Ungerstedt, Johanna, Holm, Mette Skov, Nilsson, Lars, Kittang, Astrid Olsnes, Antunovic, Peter, Rohon, Peter, Andersen, Mette Klarskov, Papaemmanuil, Elli, Bernard, Elsa, Jädersten, Martin, Hellström-Lindberg, Eva, Grønbæk, Kirsten, Ljungman, Per, Friis, Lone Smidstrup

“…•Mutations were detected in 94% of patients at the time of transplantation.•Complete remission was not associated with better outcomes, perhaps due to high…”
Get full text

Allogeneic Hematopoietic Cell Transplantation of Adult Patients with Chronic Myelomonocytic Leukemia. A Nordic Retrospective Study by Friis, LS, Wedge, E, Dybedal, I, Creignou, M, Ejerblad, E, Lorenz, F, Werlenius, O, Holm, MS, Nilsson, L, Kittang, AO, Antunovic, P, Rohon, P, Hansen, JW, Andersen, MK, Jadersten, M, Hellstrom-Lindberg, E, Gronbaek, K, Ljungman, P

Get full text